CD106 Antibodies

The CD106 antigen, also known as Vascular Cell Adhesion Molecule-1 (VCAM-1), is an adhesion molecule which binds to integrin α4/β1 (VLA‑4) and integrin α4/β7 on lymphocytes. It is a 110 kDa cell surface sialoglycoprotein belonging to the immunoglobulin superfamily. CD106 contains 7 Ig-like C2-type (immunoglobulin-like) domains. CD106 antigen is present on activated endothelial cells, tissue macrophages, dendritic cells and bone marrow fibroblasts. It is involved in the adhesion of lymphocytes, monocytes and eosinophils to activated endothelium. Recent studies shown that CD106 identifies a unique subpopulation of Mesenchymal Stem Cells (MSCs) with powerful immunosuppressive activity.
Clone: 1G11 Isotype: IgG1 Mouse
The 1G11 antibody inhibits T lymphocyte adhesion to TNF-stimulated endothelial cells.
Resources + Tools
FAQs Panel Design Product Listing Quality Standards Request a Quote Software

Explore CD106 Antibodies

Content and Resources

Immunophenotyping reference table - For haematopoietic malignancies Poster - Immunophenotyping reference table - For haematopoietic malignancies
How do I preserve sensitivity? Poster - How to preserve sensitivity
IVDR: a new era for In-Vitro Diagnostic Medical Devices BEC Marseille IVDR team, in the framework of the IVDR Global program, has established and deployed a robust project plan to fulfill IVDR requirements of more than 230 IVD CE marked products for May 2022
Flow-cytometry-reagents-focus-on-quality
Mesenchymal Stem Cells (MSC) - Conjugated Antibody Portfolio CD133-APC completed conjugated antibody portfolio for basic mesenchymal progenitor cells studies